Effect of Central Injection of Anandamide on LPS-Dependent Suppression of GnRH/LH Secretion in Ewes During the Follicular Phase of the Estrous Cycle
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311246 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Karolina Wojtulewicz und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland. Hauptthemen laut MEDLINE: Endocannabinoids, Polyunsaturated Alkamides, Arachidonic Acids, Lipopolysaccharides. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences.
Abstract (Originalsprache)
The study investigated the effects of intracerebroventricular (ICV) administration of the endocannabinoid anandamide (AEA) on suppression of gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) secretion during lipopolysaccharide (LPS)-induced inflammation in ewes at the follicular phase of the estrous cycle. Animals were divided into three groups: control, LPS (intravenous, IV; 400 ng/kg), and LPS + AEA (ICV; 100 µM/animal). In LPS-treated ewes, AEA increased GnRH concentration in the preoptic area (POA) and upregulated GnRH mRNA expression in the POA and anterior hypothalamus (AHA). Central administration of AEA decreased the circulating concentration of cortisol in LPS-treated ewes. Moreover, AEA lowered proinflammatory interleukin (IL)-1β and increased anti-inflammatory IL-10 protein expressions in the hypothalamus of LPS-treated ewes. However, ICV AEA did not reverse the inflammation-associated reduction in LH secretion. These findings show that acute central administration of AEA abolishes the inhibitory effect of inflammation on GnRH synthesis in the POA and even stimulates it, likely through attenuation of central inflammation, as reflected by IL-1β and IL-10 changes in the POA. Nevertheless, short-term AEA administration was insufficient to counteract the inflammation-mediated suppression of LH secretion. Further studies are needed to explore the role of endocannabinoids (ECBs) in modulating GnRH/LH secretion under inflammatory conditions, particularly with prolonged exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.
ORCID-Profile: Karolina Wojtulewicz, Dorota Tomaszewska-Zaremba, Monika Tomczyk, Joanna Bochenek, Andrzej P Herman
Förderung
- Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences
Zitieren
APA
Wojtulewicz, K., Tomaszewska-Zaremba, D., Tomczyk, M., Bochenek, J., & Herman, A. P. (2025). Effect of Central Injection of Anandamide on LPS-Dependent Suppression of GnRH/LH Secretion in Ewes During the Follicular Phase of the Estrous Cycle. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311246
Vancouver
Wojtulewicz K, Tomaszewska-Zaremba D, Tomczyk M, Bochenek J, Herman AP. Effect of Central Injection of Anandamide on LPS-Dependent Suppression of GnRH/LH Secretion in Ewes During the Follicular Phase of the Estrous Cycle. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311246
BibTeX
@article{Wojtulewicz2025,
author = {Wojtulewicz, Karolina and Tomaszewska-Zaremba, Dorota and Tomczyk, Monika and Bochenek, Joanna and Herman, Andrzej P},
title = {Effect of Central Injection of Anandamide on LPS-Dependent Suppression of GnRH/LH Secretion in Ewes During the Follicular Phase of the Estrous Cycle},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311246}
}
EUVIMED